TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33012544

Group type: EXPERIMENTAL
Intervention: Favorable attitude toward organ donation
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Willingness to donate organs
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Awareness
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Membership in Red Cross Association
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Laboratory technologist
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Medical doctor
Number of subjects: 382
Study: 34862661

Group type: EXPERIMENTAL
Intervention: isCGM intervention group (n = 33)
Number of subjects: 64

Group type: COMPARATOR
Intervention: SMBG control group (n = 31)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: isCGM intervention group
Number of subjects: 64
Study: 34503644

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin hydrochloride 250 mg (test product)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ciprofloxacin hydrochloride 250 mg (reference product)
Number of subjects: 48
Study: 33158415

Group type: EXPERIMENTAL
Intervention: Fishmeal-based diet labeled with stable isotopes 15N and 13C at inclusion levels of 2% and 1%, respectively, during a 12-day feed conversion test.
Number of subjects: 2281

Group type: EXPERIMENTAL
Intervention: High carbon and nitrogen metabolism in the liver.
Number of subjects: 2281

Group type: EXPERIMENTAL
Intervention: Transcriptomic analysis of liver.
Number of subjects: 2281
Study: 32660329

Group type: EXPERIMENTAL
Intervention: Experimental malingering condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition Discrimination (RD) score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FCR trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RD
Number of subjects: 0
Study: 34391923

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Non-endoscopic sphincterotomy (non-ES)
Number of subjects: 370
Study: 34772398

Group type: EXPERIMENTAL
Intervention: AH Plus sealer
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Silver nanoparticle-modified AH Plus sealer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Negative control (filled without sealer)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Positive control (filled without sealer)
Number of subjects: 40
Study: 33216667

Group type: EXPERIMENTAL
Intervention: Closed-loop control (CLC) insulin delivery system
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sensor augmented pump (SAP)
Number of subjects: 63
Study: 33378487

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) performed every activation (experimental group; EG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional sliding mechanics (control group; CG)
Number of subjects: 24
Study: 35334629

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) rehabilitation program
Number of subjects: 75
Study: 32746137

Group type: EXPERIMENTAL
Intervention: Pyramid Non‐local UNet (PN‐UNet) for landmark detection
Number of subjects: 10000
Study: 37552643

Group type: EXPERIMENTAL
Intervention: Multicomponent early childhood development intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Local standard of care (control)
Number of subjects: 0
Study: 34444627

Group type: EXPERIMENTAL
Intervention: Reflective practice journal
Number of subjects: 0
Study: 33022483

Group type: EXPERIMENTAL
Intervention: Healthy Body Image (HBI) intervention
Number of subjects: 2446

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2446
Study: 35790509

Group type: EXPERIMENTAL
Intervention: Stomatognathic system functional exercise (SSFE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Maxillary full dentition occlusal splint
Number of subjects: 60
Study: 34460140

Group type: EXPERIMENTAL
Intervention: Approach Bias Modification (ABM) with real tDCS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Approach Bias Modification (ABM) with sham tDCS
Number of subjects: 15
Study: 35060542

Group type: EXPERIMENTAL
Intervention: Folic acid (FA) tablets 0.8 mg and oral levamlodipine besylate 2.5 mg, once a day for 12 weeks, followed by adjusted FA dose for another 12 weeks
Number of subjects: 126

Group type: COMPARATOR
Intervention: Oral levamlodipine besylate tablets 2.5 mg and placebo, once a day
Number of subjects: 126
Study: 33144358

Group type: EXPERIMENTAL
Intervention: Participatory organisational workplace intervention
Number of subjects: 3012
Study: 33377285

Group type: EXPERIMENTAL
Intervention: MP-gel applied as SCT (short contact therapy) once daily (evening application) with complete removal after 1 hour using a gentle cleanser
Number of subjects: 46

Group type: COMPARATOR
Intervention: MP-gel used as SAT (standard application therapy) once daily (evening application)
Number of subjects: 46
Study: 33871486

Group type: EXPERIMENTAL
Intervention: Light curing 120 seconds after cement injection (SG3)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No light curing (SG1)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Light curing 20 seconds after cement injection (SG2)
Number of subjects: 48
Study: 32826768

Group type: EXPERIMENTAL
Intervention: Sub-flap Mattress Suture with Deep Sclerectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard Surgery
Number of subjects: 20
Study: 34467450

Group type: EXPERIMENTAL
Intervention: Mini Hyrax
Number of subjects: 34

Group type: COMPARATOR
Intervention: Hyrax
Number of subjects: 34
Study: 33413744

Group type: EXPERIMENTAL
Intervention: TQLB with 0.6 ml/kg of 0.5% ropivacaine plus general anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (general anesthesia alone)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TQLB group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 36060955

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once or two times daily) with metformin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vildagliptin (50 mg once or two times daily) with metformin
Number of subjects: 120
Study: 34465265

Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin (belamaf)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selinexor plus dexamethasone (SEL+DEX)
Number of subjects: 0
Study: 36462038

Group type: EXPERIMENTAL
Intervention: NP + TE (nanofilled composite and 2-step total-etch adhesive system)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NP + UA (nanofilled composite and universal adhesive system)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MH + TE (microhybrid composite and 2-step total-etch adhesive)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MH + UA (microhybrid composite and universal adhesive)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MH + TE
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NP + TE
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study: 33611640

Group type: EXPERIMENTAL
Intervention: Knee arthroscopy
Number of subjects: 50
Study: 32721919

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) 0.3 ug/kg, administered 30 min once a day after surgery
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (saline 50 ml for 30 min)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 59
Study: 34981449

Group type: EXPERIMENTAL
Intervention: Islamic-based intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 62
Study: 32419114

Group type: EXPERIMENTAL
Intervention: Psychosocial treatments emphasizing learning skills and strategies (82.5% preference among parents)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Involvement of parents in treatment (96.8% preference among parents)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Therapist meeting mostly with youth alone (67.2% preference among youth)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Sharing information with parents (78.1% preference among youth)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Response of 'don't know' to preferred therapeutic approach (43.8% among youth)
Number of subjects: 127
Study: 36111906

Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 32632880

Group type: EXPERIMENTAL
Intervention: Liver-directed surgical approaches and locally ablative procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiographic liver-directed techniques (transarterial embolization, chemoembolization, radioembolization)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peptide receptor radionuclide therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various systemic medical therapies
Number of subjects: 0
Study: 35701830

Group type: EXPERIMENTAL
Intervention: Oral naproxen 500 mg twice daily for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32303041

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (work‐coping group WG)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Recreational group (recreational group RG)
Number of subjects: 107
Study: 35958676

Group type: EXPERIMENTAL
Intervention: Surgical neurolysis
Number of subjects: 10
Study: 33459040

Group type: EXPERIMENTAL
Intervention: Bright white light (BWL) exposure (1260 lux at 20 inches, 440–480 nanometers) for 30 minutes each morning
Number of subjects: 131

Group type: COMPARATOR
Intervention: Red light exposure (<450 lux, no light between 440 and 480 nanometers) for 30 minutes each morning
Number of subjects: 131
Study: 32932234

Group type: EXPERIMENTAL
Intervention: RS-OP
Number of subjects: 12

Group type: COMPARATOR
Intervention: RS-NO
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CP-NO
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CP-OP
Number of subjects: 12
Study: 35820447

Group type: EXPERIMENTAL
Intervention: Priming (2 sets high-load parallel squats with a 20% velocity loss cut-off)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Priming
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 33548897

Group type: EXPERIMENTAL
Intervention: Aprepitant (320 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35220062

Group type: EXPERIMENTAL
Intervention: Rhythmic Auditory Stimulation (RAS) during treadmill gait training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-RAS treadmill gait training
Number of subjects: 50
Study: 34425320

Group type: EXPERIMENTAL
Intervention: Healthy diet supplemented with 30 mL/d of extra virgin olive oil (OOG)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Healthy diet supplemented with 30 g/d of pecans (PNG)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Healthy diet based on guidelines (control group [CG])
Number of subjects: 149
Study: 34477459

Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin
Number of subjects: 11016

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 11016
Study: 33296484

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique + Nerve Stimulator
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nerve stimulator
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combination group (Ultrasound-guided technique + Nerve Stimulator)
Number of subjects: 66

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 66
Study: 35015168

Group type: EXPERIMENTAL
Intervention: Spinal Anaesthesia (SA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local Anaesthesia (LA)
Number of subjects: 60
Study: 34232000

Group type: EXPERIMENTAL
Intervention: PLLA reconstituted with 8 mL sterile water for injection (SWFI) including 1 mL 2% lidocaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: PLLA reconstituted with 5 mL sterile water for injection (SWFI)
Number of subjects: 80
Study: 32933499

Group type: EXPERIMENTAL
Intervention: Sandwich principle lecture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Classical face-to-face lecture
Number of subjects: 64
Study: 35413837

Group type: EXPERIMENTAL
Intervention: High green leafy vegetable dietary intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 33121980

Group type: EXPERIMENTAL
Intervention: Pitolisant (titrated individually at up to 20 mg/day for 12 weeks)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Pitolisant
Number of subjects: 244
Study: 32224119

Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Electrical Acupuncture (EA)
Number of subjects: 66
Study: 36335909

Group type: EXPERIMENTAL
Intervention: CDE alongside home‐based chest physiotherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chest physiotherapy and home‐based walking program
Number of subjects: 24
Study: 33367621

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily)
Number of subjects: 19114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study: 32474426

Group type: EXPERIMENTAL
Intervention: Target-specific anticancer drugs
Number of subjects: 433
Study: 35503787

Group type: EXPERIMENTAL
Intervention: Super-circuit training (SCT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Moderate-intensity continuous-aerobic training (CAT)
Number of subjects: 29
Study: 33671147

Group type: EXPERIMENTAL
Intervention: RS2-enriched wheat rolls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional wheat rolls
Number of subjects: 0
Study: 33778993

Group type: EXPERIMENTAL
Intervention: Body height measurement
Number of subjects: 4046

Group type: EXPERIMENTAL
Intervention: Body mass and BMI measurement
Number of subjects: 4046

Group type: EXPERIMENTAL
Intervention: Motor abilities tests
Number of subjects: 4046

Group type: EXPERIMENTAL
Intervention: Correlation analysis of body mass, BMI, and body height with motor abilities
Number of subjects: 4046
Study: 34851251

Group type: EXPERIMENTAL
Intervention: Ularitide as a continuous intravenous infusion during hospitalisation as an add-on to any diuretic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo as a continuous intravenous infusion during hospitalisation as an add-on to any diuretic treatment
Number of subjects: 0
Study: 32270862

Group type: EXPERIMENTAL
Intervention: tesamorelin
Number of subjects: 61

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study: 33115376

Group type: EXPERIMENTAL
Intervention: Total fertility rate
Number of subjects: 25144

Group type: EXPERIMENTAL
Intervention: Crude birth rate
Number of subjects: 25144

Group type: EXPERIMENTAL
Intervention: Crude death rate
Number of subjects: 25144

Group type: EXPERIMENTAL
Intervention: Dependency ratio
Number of subjects: 25144

Group type: EXPERIMENTAL
Intervention: Birth rates in urban residents
Number of subjects: 25144

Group type: EXPERIMENTAL
Intervention: Birth rates in women with basic education
Number of subjects: 25144

Group type: EXPERIMENTAL
Intervention: Number of deaths reported
Number of subjects: 25144

Group type: EXPERIMENTAL
Intervention: Life expectancy
Number of subjects: 25144
Study: 36433792

Group type: EXPERIMENTAL
Intervention: Family centered Function‐focused Care (Fam‐FFC)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 140
Study: 33910333

Group type: EXPERIMENTAL
Intervention: KCd (Carfilzomib + Cyclophosphamide + Dexamethasone)
Number of subjects: 300

Group type: COMPARATOR
Intervention: VCd (Bortezomib + Cyclophosphamide + Dexamethasone)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Carfilzomib maintenance
Number of subjects: 300
Study: 616741974

Group type: EXPERIMENTAL
Intervention: Low-dose group (1850 MBq)
Number of subjects: 278

Group type: COMPARATOR
Intervention: High-dose group (3700 MBq)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 278
Study: 36204963

Group type: EXPERIMENTAL
Intervention: Immediate implantation group (17 implants)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Delayed implantation group (19 implants)
Number of subjects: 30
Study: 34455706

Group type: EXPERIMENTAL
Intervention: edoxaban
Number of subjects: 88
Study: 32444149

Group type: EXPERIMENTAL
Intervention: Forefoot strike (FFS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Cadence (CAD)
Number of subjects: 39
Study: 35730535

Group type: EXPERIMENTAL
Intervention: Dual use of oral tobacco-derived nicotine (OTDN) products (VERVE chews/discs)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Exclusive use of discs or chews
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Dual use of discs/chews
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Exclusive use of discs/chews
Number of subjects: 213

Group type: COMPARATOR
Intervention: Continue smoking
Number of subjects: 213
Study: 33542071

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure targets (<130 mm Hg)
Number of subjects: 5001

Group type: COMPARATOR
Intervention: Standard blood pressure targets (≥130 mm Hg)
Number of subjects: 5001
Study: 32093709

Group type: EXPERIMENTAL
Intervention: Forum theater sessions (2 sessions)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Being an actor in forum theater
Number of subjects: 488
Study: 34039576

Group type: EXPERIMENTAL
Intervention: Delivery catheter
Number of subjects: 70

Group type: COMPARATOR
Intervention: Stylet
Number of subjects: 70
Study: 34233204

Group type: EXPERIMENTAL
Intervention: Etch‐and‐rinse (Variolink N)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self‐etch (Panavia F2.0)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self‐adhesive (RelyX Unicem)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 32251026

Group type: EXPERIMENTAL
Intervention: siponimod
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ocrelizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: anti-inflammatory drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: neuroprotective drugs
Number of subjects: 0
Study: 34474131

Group type: EXPERIMENTAL
Intervention: Zenith Alpha™ abdominal stent graft
Number of subjects: 347
Study: 32883555

Group type: EXPERIMENTAL
Intervention: Trivalent GBS vaccine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 36323243

Group type: EXPERIMENTAL
Intervention: AM‐301 (bentonite nasal spray)
Number of subjects: 36

Group type: COMPARATOR
Intervention: HPMC (Nasaleze® Allergy Blocker)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of AM‐301 to HPMC
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: AM‐301
Number of subjects: 36

Group type: COMPARATOR
Intervention: HPMC
Number of subjects: 36

Group type: COMPARATOR
Intervention: AM‐301 and HPMC
Number of subjects: 36
Study: 34759146

Group type: EXPERIMENTAL
Intervention: High-dose Methotrexate (HD-MTX) continued-maintenance therapy (3.5g/m2)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Chemoradiotherapy consisting of HD-MTX followed by whole-brain radiotherapy (WBRT)
Number of subjects: 52
Study: 32078493

Group type: EXPERIMENTAL
Intervention: Personalized autoregulation-based BP targets
Number of subjects: 90

Group type: COMPARATOR
Intervention: Static systolic BP thresholds (140 mm Hg and 160 mm Hg)
Number of subjects: 90
Study: 35274420

Group type: EXPERIMENTAL
Intervention: KCCQ-PLS improvement
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: KCCQ-PLS deterioration
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: KCCQ-PLS meaningful change
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: KCCQ-PLS AUC analysis
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: KCCQ-PLS minimal clinically important difference
Number of subjects: 698
Study: 32740778

Group type: EXPERIMENTAL
Intervention: Systemic Assessment Clinic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard assessment
Number of subjects: 0
Study: 33201089

Group type: EXPERIMENTAL
Intervention: Colostomy with synthetic, lightweight monofilament mesh (Group B)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Colostomy without mesh (Group A)
Number of subjects: 200
Study: 32090699

Group type: EXPERIMENTAL
Intervention: Phylloquinone (vitamin K1) supplementation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Baseline plasma phylloquinone concentrations
Number of subjects: 48
Study: 33586819

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy programme without additional videoconference sessions
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy programme with additional videoconference sessions
Number of subjects: 77

Group type: COMPARATOR
Intervention: Both groups (iCBT with and without videoconference guidance)
Number of subjects: 77
Study: 34786956

Group type: EXPERIMENTAL
Intervention: Tanezumab 5 mg every 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tanezumab 10 mg every 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Celecoxib 200 mg/day
Number of subjects: 0
Study: 34305792

Group type: EXPERIMENTAL
Intervention: Mirror visual feedback prior to robot-assisted training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham-mirror visual feedback prior to robot-assisted training
Number of subjects: 40
Study: 35416456

Group type: EXPERIMENTAL
Intervention: Cervical total disc replacement (CTDR)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 72
Study: 36153623

Group type: EXPERIMENTAL
Intervention: Mindfulness-based Tai Chi Chuan (MBTCC)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Sleep hygiene education (SHE)
Number of subjects: 256
Study: 34052118

Group type: EXPERIMENTAL
Intervention: Self-help relaxation exercise twice per day for 4 weeks
Number of subjects: 30
Study: 32912351

Group type: EXPERIMENTAL
Intervention: Imagery-enhanced CBT (IE-CBT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Verbally-based CBT (VB-CBT)
Number of subjects: 107
Study: 33604488

Group type: EXPERIMENTAL
Intervention: Traditional marine diet (high fat, low carbohydrate)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western diet
Number of subjects: 60
Study: 33484279

Group type: EXPERIMENTAL
Intervention: Burosumab
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 35